SCM
Sarissa Capital Management Portfolio holdings
AUM
$154M
This Quarter Return
+12.33%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$514M
AUM Growth
+$514M
(+27%)
Cap. Flow
+$87.7M
Cap. Flow
% of AUM
17.06%
Top 10 Holdings %
Top 10 Hldgs %
96.45%
Holding
21
New
2
Increased
3
Reduced
1
Closed
4
Top Buys
1 |
Biogen
BIIB
|
$95M |
2 |
Pacira BioSciences
PCRX
|
$11.7M |
3 |
ARRY
Array Biopharma Inc
ARRY
|
$2.95M |
4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$1.88M |
5 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$253K |
Top Sells
1 |
Merck
MRK
|
$19.8M |
2 |
KIN
Kindred Biosciences, Inc.
KIN
|
$3.58M |
3 |
Gyre Therapeutics
GYRE
|
$419K |
4 |
RPRX
Repros Therapeutics Inc.
RPRX
|
$159K |
5 |
Carisma Therapeutics
CARM
|
$99K |
Sector Composition
1 | Healthcare | 88.49% |